negative pion therapy employing dynamic scanning focused spot convergent beams use NUMBER sin conformation treatment volume target volume achieved following previously reported phase ib clinical trials phase ii trial initiated goal treating primary tumors dose optimization schedule included stepwise increase total pion dose target volume patients multicentric superficial bladder tumors cystectomy candidates initially selected invasive cases treated graded scoring acute tissue reactions employed periods NUMBER NUMBER months pion dose escalation ranged NUMBER rad minimum NUMBER rad minimum NUMBER fractions NUMBER weeks treatment volumes encompassed NUMBER cc local NUMBER cc extended volume therapy treatment reactions ranged faint erythema increase bladder frequency dry desquamation mild nausea moderate dysuria moderate proctitis diarrhea mucus reactions closely related treatment volume site severe late cystitis occurred patient treated NUMBER courses pions NUMBER rad mild moderate late proctitis seen NUMBER patients NUMBER bladder cancer patients local control disease NUMBER pancreas biliary tract cancer patients microscopic residual disease locally time death metastasis total NUMBER NUMBER patients clinically pathologically free local tumor time observation pi meson dimensional deep seated follow